JS BIOFUTURE INVEST ApS: Financial statements 2024
CVR: 31080983
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -19,100 and a net result of DKK -8,609 compared with DKK -24,077 the year before. Equity in the 2024 report amounted to DKK 214,506. The solvency ratio was 25.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -19,100
- Profit/Loss
- DKK -8,609
- Equity
- DKK 214,506
- Total Assets
- DKK 829,129
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -19K | -9K | 215K | 1 |
| 2023 | - | -15K | -24K | 223K | - |
| 2022 | - | -14K | -5K | 247K | 0 |
| 2021 | - | -66K | -45K | 252K | - |
| 2020 | - | -17K | 120K | 297K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
JS BIOFUTURE INVEST ApS has published its annual report for 2023. Gross profit came to DKK -15,348, and the net result was DKK -24,077.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.